Secondary |
Bipolar I Disorder |
17.4% |
Schizophrenia, Paranoid Type |
16.7% |
Bipolar Disorder |
10.1% |
Drug Use For Unknown Indication |
6.6% |
Product Used For Unknown Indication |
6.6% |
Constipation |
5.9% |
Depression |
5.9% |
Mania |
5.6% |
Schizophrenia |
5.6% |
Parkinson's Disease |
4.2% |
Interstitial Lung Disease |
3.5% |
Insomnia |
2.4% |
Affective Disorder |
2.1% |
Major Depression |
2.1% |
Hypertension |
1.7% |
Partial Seizures |
1.0% |
Anxiety |
0.7% |
Benign Prostatic Hyperplasia |
0.7% |
Delusional Disorder, Unspecified Type |
0.7% |
Depressive Symptom |
0.7% |
|
Therapeutic Agent Toxicity |
12.7% |
Somnolence |
10.9% |
Liver Disorder |
7.3% |
Stevens-johnson Syndrome |
7.3% |
Tremor |
7.3% |
White Blood Cell Count Increased |
7.3% |
Renal Impairment |
5.5% |
Somnolence Neonatal |
5.5% |
Vomiting |
5.5% |
Delirium |
3.6% |
Malaise |
3.6% |
Neuroleptic Malignant Syndrome |
3.6% |
Rash |
3.6% |
Sick Sinus Syndrome |
3.6% |
Water Intoxication |
3.6% |
Anaphylactic Reaction |
1.8% |
Aspartate Aminotransferase Increased |
1.8% |
Autoimmune Thyroiditis |
1.8% |
Blood Creatine Phosphokinase Increased |
1.8% |
Decreased Appetite |
1.8% |
|
Concomitant |
Bipolar Disorder |
16.2% |
Bipolar I Disorder |
15.2% |
Depression |
12.5% |
Insomnia |
8.1% |
Schizophrenia |
6.7% |
Schizophrenia, Paranoid Type |
5.1% |
Product Used For Unknown Indication |
4.6% |
Sleep Disorder |
4.0% |
Schizophrenia, Disorganised Type |
3.9% |
Constipation |
3.6% |
Substance-induced Psychotic Disorder |
3.5% |
Asthma |
2.7% |
Prophylaxis |
2.6% |
Schizophrenia, Undifferentiated Type |
2.2% |
Hypertension |
1.7% |
Anxiety |
1.6% |
Bipolar Ii Disorder |
1.6% |
Drug Use For Unknown Indication |
1.5% |
Schizoaffective Disorder |
1.3% |
Hyperlipidaemia |
1.3% |
|
White Blood Cell Count Increased |
13.5% |
Vomiting |
10.7% |
Rhabdomyolysis |
9.6% |
Rash |
8.4% |
White Blood Cell Count Decreased |
6.7% |
Tremor |
5.6% |
Stevens-johnson Syndrome |
4.5% |
Mania |
3.9% |
Pyrexia |
3.9% |
Sudden Death |
3.9% |
Completed Suicide |
3.4% |
Salivary Hypersecretion |
3.4% |
Serotonin Syndrome |
3.4% |
Hepatic Function Abnormal |
2.8% |
Interstitial Lung Disease |
2.8% |
Neuroleptic Malignant Syndrome |
2.8% |
Rash Generalised |
2.8% |
Skin Disorder |
2.8% |
Suicidal Ideation |
2.8% |
Granulocyte Count Decreased |
2.2% |
|
Interacting |
Depressed Mood |
33.3% |
Depressive Symptom |
33.3% |
Gonarthrosis |
33.3% |
|
Somatoform Disorder Neurologic |
50.0% |
Somnolence |
50.0% |
|